30 Years of Pharmaceutical Cost-Utility Analyses: Growth, Diversity and Methodological Improvement

Author： Neumann Peter J.   Fang Chi-Hui   Cohen Joshua T.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.10, 2009-10, pp. : 861-872

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children: Theoretical and Methodological Considerations

By Prosser Lisa A.  

PharmacoEconomics, Vol. 25, Iss. 9, 2007-01 ,pp. : 713-726

Adis International

Access to resources Recommend Favorite

Cost-Utility Analysis of Methadone Maintenance Treatment: A Methodological Approach

By Vanagas Giedrius   Padaiga Zilvinas   Bagdonas Eugenijus  

Substance Use & Misuse, Vol. 41, Iss. 1, 2006-06 ,pp. : 87-101

Informa Healthcare

Access to resources Recommend Favorite

Methods for Measuring Temporary Health States for Cost-Utility Analyses

By Wright Davene R.   Wittenberg Eve   Swan J. Shannon   Miksad Rebecca A.   Prosser Lisa A.  

PharmacoEconomics, Vol. 27, Iss. 9, 2009-09 ,pp. : 713-723

Adis International

Access to resources Recommend Favorite

Valuing Children's Health: A Comparison of Cost-Utility Analyses for Adult and Paediatric Health Interventions in the US

By Ladapo Joseph A.  

PharmacoEconomics, Vol. 25, Iss. 10, 2007-01 ,pp. : 817-828

Adis International

Access to resources Recommend Favorite

How Often Do Sensitivity Analyses for Economic Parameters Change Cost-Utility Analysis Conclusions?

By Schackman B.R.  

PharmacoEconomics, Vol. 22, Iss. 5, 2004-01 ,pp. : 293-300

Adis International

Access to resources Recommend Favorite